Publications by authors named "Nancy Fusco"

Claim this Profile
R
Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer.
Anita Schwandt, Vivian E von Gruenigen, Robert M Wenham, Heidi Frasure, Susan Eaton, Nancy Fusco

Invest New Drugs· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.
Charles A Kunos, Tomas Radivoyevitch, Steven Waggoner, Robert Debernardo, Kristine Zanotti, Nancy Fusco

Gynecol Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies.
Charles A Kunos, James Brindle, Steven Waggoner, Kristine Zanotti, Kimberly Resnick, Nancy Fusco

Front Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies: a phase I study.
Vivian E von Gruenigen, Heidi E Frasure, Deborah A Smith, Nancy L Fusco, Susan M Eaton

Anticancer Drugs· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group study.
Peter G Rose, Michael W Sill, D Scott McMeekin, Amina Ahmed, Ritu Salani, Nancy Fusco

Gynecol Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients.
Vivian von Gruenigen, Heidi Frasure, Nancy Fusco, Robert DeBernardo, Elisa Eldermire

Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancer.
Peter G Rose, Mary Smrekar, Pam Haba, Nancy Fusco, Michael Rodriguez

Am J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study.
Peter G Rose, Koen Degeest, Scott McMeekin, Nancy Fusco

Gynecol Oncol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: a phase I study of the Gynecologic Oncology Group.
Peter G Rose, Benjamin E Greer, Ira R Horowitz, Maurie Markman, Nancy Fusco

Gynecol Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy.
Vivian E von Gruenigen, Jessica R Hutchins, Anne Marie Reidy, Heidi E Gibbons, Barbara J Daly, Nancy L Fusco

Health Qual Life Outcomes· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group study.
Peter G Rose, Maurie Markman, Jeffrey G Bell, Nancy L Fusco

Gynecol Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma.
Peter G Rose, Mary Smrekar, Nancy Fusco

Gynecol Oncol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity.
Peter G Rose, Nancy Fusco, Mary Smrekar, Kim Mossbruger, Michael Rodriguez

Gynecol Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine reverses cisplatin resistance: demonstration of activity in platinum- and multidrug-resistant ovarian and peritoneal carcinoma.
Peter G Rose, Kim Mossbruger, Nancy Fusco, Mary Smrekar, Sue Eaton

Gynecol Oncol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Peter G Rose, Michael Rodriguez, Joan Walker, Benjamin Greer, Nancy Fusco

Gynecol Oncol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis